NUDT1 and glioblastoma: The TCGA [18, 19], the REMBRANDT [20] and Gravendeel [21] data collections all provided consistent evidence that MTH1 mRNA expression was higher in GBM compared to non-tumor brain tissue and low grade GBM (WHO grade II and III; Figure 1, Supplementary Figure S1).